Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sera Prognostics, Inc.
Age
18–55
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subject is 18 years of age or older
Subject has singleton gestation
Subject is able to provide consent
Gestational age is confirmed by a documented crown rump length on an ultrasound performed at the study site within 6 0/7 weeks and 13 6/7 weeks gestation (first trimester)
Subject has no signs and/or symptoms of preterm labor and has intact membranes
Investigator believes subject is willing to comply with study visits and procedures
Investigator believes the subject's delivery data will be available within 15 business days from delivery, and neonatal data will be available for data collection purposes within 15 business days from discharge
You may not be if
The subject has a planned cesarean section or induction of labor prior to 370/7 weeks of gestation
The subject has a planned cerclage placement for the current pregnancy
There is a known or suspected fetal anomaly or chromosomal abnormality
The subject has had a blood transfusion during the current pregnancy
The subject has known elevated bilirubin levels (hyperbilirubinemia)
The subject has taken or plans to take any of the following medications during the current pregnancy:
* Progesterone or progesterone-derivative medication after 13 6/7 weeks gestation
* Enoxaparin, heparin, heparin sodium, low molecular weight heparin after first day of last menstrual period
The subject has participated in, or plans to participate in, an interventional treatment study during the current pregnancy
The current pregnancy was previously a multiple gestation that is now a single fetus due to reduction, vanishing twin, etc.
Clareo Health | A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
